Cite
HARVARD Citation
Moorman, A. et al. (2020). Adjuvant tyrosine kinase inhibitor therapy improves outcome for children and adolescents with acute lymphoblastic leukaemia who have an ABL‐class fusion. British journal of haematology. pp. 844-851. [Online].